Benefits of Cross-Trading in the U.S.

For many international companies, the successful listing of their security represents an important milestone.  It’s a sign of recognition, prestige and success, demonstrating to the market a desire to be open and transparent.  There are many reasons why a company may choose to list its shares – to raise capital, increase its valuation and diversify its shareholder base.  But many companies are unaware that there are limitations as to what can be achieved by solely listing in their home (primary) market.   Many do not realize that U.S. investors are often unwilling or unable to invest in foreign markets, and that the information they disclose locally may not be widely-available in the U.S.  So, what is the best way to bridge this gap and access the world’s largest market for capital expansion and growth? Cross-trading.

Access to U.S. Capital Markets Increasingly Important for Foreign Issuers

Access to the U.S. Capital Markets has become even more important for foreign issuers,as they look to determine the most efficient and effective way to expand their investor base.  Cross-trading on a secondary market enables companies to establish a footprint and access a U.S. shareholder base.  Many U.S. investors prefer to see quotes in U.S. dollars during their regular trading hours.

To provide this access and to facilitate trade reporting, broker-dealers request the trading symbols or tickers of foreign securities in the U.S. These ticker symbols are 5 letters long and end with either the letter “F” or “Y.”  Tickers that end in “F” are the ordinary shares of a company.  In most cases, these securities trade and settle in the local market but are quoted in U.S. dollars for investors.  Many jurisdictions allow for F shares to settle within the U.S., making it even more advantageous for U.S. investors.  Shares that end in “Y” are American Depositary Receipts (ADRs) that are issues by ADR banks.  ADRs represent the shares of a non-U.S. company that trades in the U.S. financial markets.  They carry prices in U.S. dollars, pay dividends in U.S. dollars, and may be traded like the shares of U.S.-based companies.

More than 2,000 companies with primary listings on more than 30 global markets, such as London, Frankfurt, Paris, Madrid, Milan, Toronto and Tokyo have an F share and/or an ADR trading on OTC Markets.

What are the Benefits of Cross-trading?

There are numerous benefits to Cross-Trading in the U.S:

  • Diversifying your shareholder base
  • Making your financial information, research, pricing and risk assessment more broadly available to U.S. investors
  • Appealing to those investors who prefer securities traded domestically in U.S. dollars
  • Enhancing visibility among broker-dealers by supporting broker and sell-side compliance

A national U.S. exchange, such as NYSE or Nasdaq, may be perceived to be the natural home and fit for foreign issuers looking to access a deep pool of institutional investors. However, foreign issuers are subject to U.S. exchange requirements and different accounting standards that can become duplicative, time-consuming and cost-prohibitive for global IROs with limited budgets.

On the contrary, International companies that trade on the OTCQX® Best Market, the premium tier of OTC Markets Group, can leverage their existing reporting standards and make disclosures available in the U.S utilizing SEC reporting exemption Rule 12g32(b).

Unlike the exchanges, there are no Sarbanes-Oxley and SEC Reporting requirements to trade on OTCQX — helping to remove trading restrictions, complementing a company’s home market reporting and alleviating the burdensome, costly and duplicative exchange requirements.

Synergies Create Opportunities for Enhanced Liquidity 

Cross-trading also presents reciprocal opportunities for issuers to enhance liquidity in both their home market and abroad.  On average, companies experience a home market liquidity increase of 26% and an OTC Market increase of 67% after joining the OTCQX Market, as evidenced by a recent study by Oxford Metrica. This provides international issuers with an alternative, cost-effective trading environment in which to raise capital, increasing the effectiveness of investor relations programs and further building global investor awareness.

In addition to the positive impact of enhanced liquidity in both the home market and on the OTC Market, a first-of-its kind strategic alliance between OTC Markets Group and the Canadian Securities Exchange (CSE) demonstrates the synergies that can be created between a national exchange and OTC Markets Group.  Our collaboration with Canadian Securities Exchange CEO Richard Carleton validates that international issuers benefit from secondary trading on OTC Markets’ OTCQX Best Market/OTCQB Venture Market.  Investors and the broker dealer community gain greater access to a breadth of financial information, increased global investing opportunities and more efficient trading.

“We see first-hand the value created for companies that choose to cross-trade on OTCQX. These companies experience greater liquidity in the Canadian Market while also increasing their percentage of US ownership.”

– Richard Carleton, Chief Executive Officer, Canadian Securities Exchange

Fundamentally, cross-trading provides a more turnkey approach and a unique opportunity for international companies seeking to bridge the gap and broaden their global reach — paving the way for capital expansion and growth opportunity.

Visit for more information about cross-trading and accessing the OTCQX and OTCQB Markets.


Jason Paltrowitz is Executive Vice President, Corporate Services at OTC Markets Group, where he is responsible for managing the firm’s international and domestic Corporate Services business. Drawing upon his expertise in cross-border trading and as a recognized proponent of Reg A+ and small company capital raising, Jason is an advocate for small cap issuers, start-ups, and entrepreneurial innovators working to alleviate the cost, time and complexity associated with being a public company. Prior to joining OTC Markets in October 2013, Jason was Managing Director and Segment Head at JP Morgan Chase responsible for the custody, clearing and collateral management business in the Corporate and Investment Bank division. Jason also held multiple senior management positions at BNY Mellon, most notably, as Head of M&A for the Financial Markets and Treasury Services Sector and 11 years as the Head of the Global Capital Markets Group in the Depositary Receipt Division. Jason currently serves on the Board of Directors of the Crowdfunding Professional Association (CfPA) and also served as a member of the Board of Directors at OTC Markets Group from 2008 – 2011. Jason holds a Bachelor's degree in International Relations from Boston University and received his MBA from the NYU Stern School of Business.

One Ping

  1. Pingback: What Are The Benefits Of Cross-Trading In The United States? | PubCoCEO™

One Comment

  1. Marcus Keep

    The OTCQX International has been an excellent venue for interested Americans for investing directly in foreign stocks.

    For example, the innovative Swedish research and development company, NeuroVive Pharmaceutical, AB, is ahead of its time, in being listed both on the OMX Nasdaq Nordic exchange in Stockholm (NVP.ST), AND on the OTCQX (ticker NEVPF). While the home country advantage Sweden stock volume is still 100+ times higher than the US volume, NEVPF has been traded every day in the USA since April 2018 as more Americans discover the company. The enhanced transparency of a OTCQX International listing gives trading confidence.

    An extra advantage to being dual-listed on exchanges in different times zones, is Swedes have started trading in NEVPF directly on the OTC Markets through the Swedish “Nordnet” brokerage, for after hours trading until 10 pm CET (when the USA markets close at 4 pm EST).

%d bloggers like this: